Completed PHASE3 INTERVENTIONAL 2-arm NCT01249846

The Efficacy and Safety of 2.5 mg Chlorhexidine Gluconate Chip (PerioChip®) in Frequent Treatment Versus Routine Treatment in Therapy of Adult Chronic Periodontitis

Sponsor: Dexcel Pharma Technologies Ltd.

Conditions Generalized Adult Periodontitis

Updated 5 times since 2017 Last updated: Jan 16, 2013 Started: Dec 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Generalized Adult Periodontitis, this trial is completed. The trial is conducted by Dexcel Pharma Technologies Ltd. and has accumulated 5 data snapshots since 2010. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Dec 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Dexcel Pharma Technologies Ltd.

Data source: Dexcel Pharma Technologies Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Haifa, Israel